Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors
- 18 June 2004
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 73 (4) , 502-507
- https://doi.org/10.1002/jmv.20118
Abstract
Using a system that allows transfection of resting peripheral blood lymphocytes (PBLs) two questions were addressed: the kinetics of HIV replication from the state of proviral latency, and the impact of different parameters on the efficacy of protease inhibitors to control HIV replication. PBLs were transfected with an infectious full length HIV-DNA harboring a luciferase reporter gene and activated thereafter. Ritonavir was added at different times at doses ranging from to 0.06 to 1 microM. Viral expression was assessed by quantifying luciferase activity in cell extracts and levels of p24 HIV antigen in culture supernatants. After transfection and cell activation, intracellular expression of HIV proteins, as assessed by luciferase detection, occurred within 2 hr. HIV-gag p24 antigen was detected in culture supernatants between 6 and 8 hr post-activation. Ritonavir was effective in blocking viral replication when given within 4 hr following HIV reactivation, but a delay in ritonavir administration or breaches in ritonavir levels after 6 hr from transfection resulted in viral escape. HIV reactivation from proviral latency in PBLs is an extremely rapid process, faster than estimated from previous models. These data stress the need for maintaining effective antiretroviral concentrations to block completely viral replication.Keywords
Funding Information
- Abbott Laboratories
- Ministerio de Ciencia y Tecnología (SAF 00/0028)
- Fundación Caja Madrid
- FIPSE (3074/99)
- Red de Investigación en SIDA (RIS)
This publication has 27 references indexed in Scilit:
- A Review of Low-Dose Ritonavir in Protease Inhibitor Combination TherapyClinical Infectious Diseases, 2003
- Latency in Human Immunodeficiency Virus Type 1 Infection: No Easy AnswersJournal of Virology, 2003
- The Challenge of Viral Reservoirs in HIV-1 InfectionAnnual Review of Medicine, 2002
- Improved estimates for H1V-1 clearance rate and intracellular delayAIDS, 1999
- Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral TherapyNew England Journal of Medicine, 1999
- Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral TherapyNew England Journal of Medicine, 1999
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structureCell, 1990
- Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compoundsJournal of Virological Methods, 1988